SEC 13F Intelligence

First American Trust, Fsb / ABT

First American Trust, Fsb’s Abbott Laboratories Position

Does First American Trust, Fsb own Abbott Laboratories (ABT)? Yes — 118.8K shares worth $12M (+0.82% of its 13F portfolio) as of Q1 2026, up from 113.3K shares the prior filed quarter.

Position Value
$12M
Q1 2026
Shares
118.8K
% of Portfolio
+0.82%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $6MQ2 ’19: $7MQ3 ’19: $7MQ4 ’19: $7MQ4 ’19Q1 ’20: $7MQ2 ’20: $8MQ3 ’20: $10MQ4 ’20: $9MQ4 ’20Q1 ’21: $8MQ2 ’21: $7MQ3 ’21: $8MQ4 ’21: $10MQ4 ’21Q1 ’22: $8MQ2 ’22: $8MQ3 ’22: $7MQ4 ’22: $8,089Q4 ’22Q1 ’23: $9,674Q2 ’23: $9,736Q3 ’23: $10MQ4 ’23: $17MQ4 ’23Q1 ’24: $18MQ2 ’24: $15MQ3 ’24: $13MQ4 ’24: $13MQ4 ’24Q1 ’25: $15MQ2 ’25: $15MQ3 ’25: $15MQ4 ’25: $14MQ4 ’25Q1 ’26: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026118.8K$12M+0.82%
Q4 2025113.3K$14M+0.97%
Q3 2025114.3K$15M+1.11%
Q2 2025113.9K$15M+1.24%
Q1 2025113.2K$15M+1.38%
Q4 2024111.4K$13M+1.26%
Q3 2024112.3K$13M+1.27%
Q2 2024142.0K$15M+1.48%
Q1 2024158.5K$18M+1.89%
Q4 2023152.0K$17M+2.07%
Q3 202399.1K$10M+1.36%
Q2 202389.3K$9,736+1.34%
Q1 202395.5K$9,674+1.44%
Q4 202273.7K$8,089+1.25%
Q3 202272.9K$7M+1.18%
Q2 202274.1K$8M+1.27%
Q1 202271.0K$8M+1.16%
Q4 202167.6K$10M+1.30%
Q3 202165.5K$8M+1.17%
Q2 202162.9K$7M+1.15%
Q1 202166.4K$8M+1.26%
Q4 202085.8K$9M+1.57%
Q3 202089.7K$10M+1.75%
Q2 202088.0K$8M+1.58%
Q1 202085.3K$7M+1.64%
Q4 201985.0K$7M+1.41%
Q3 201983.7K$7M+1.41%
Q2 201983.7K$7M+1.46%
Q1 201980.3K$6M+1.42%
Q4 201892.2K$7M+1.68%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See First American Trust, Fsb’s full portfolio or all institutional holders of ABT.